Journal of Surgical Research
Volume 142, Issue 1 , Pages 20-27 , September 2007

Neither Antioxidants nor COX-2 Inhibition Protect Against Esophageal Inflammation in an Experimental Model of Severe Reflux

  • James O. Murphy, M.R.C.S.I.

      Affiliations

    • Department of Surgery, St James’s Hospital and Trinity College, Dublin, Ireland
    • ,
  • Narayanasamy Ravi, F.R.C.S.I.

      Affiliations

    • Department of Surgery, St James’s Hospital and Trinity College, Dublin, Ireland
    • ,
  • Patrick J. Byrne, Ph.D.

      Affiliations

    • Department of Surgery, St James’s Hospital and Trinity College, Dublin, Ireland
    • ,
  • George S.A. McDonald, M.D.

      Affiliations

    • Department of Histopathology, St James’s Hospital and Trinity College, Dublin, Ireland
    • ,
  • John V. Reynolds, M.D.

      Affiliations

    • Department of Surgery, St James’s Hospital and Trinity College, Dublin, Ireland
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Department of Surgery, Trinity Centre, St. James’s Hospital, Dublin 8, Ireland.

Received 26 February 2006

References 

  1. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049
  2. Chen X, Yang CS. Esophageal adenocarcinoma: A review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis. 2001;22:1119
  3. Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr. 1999;69:1086
  4. Karin M, Cao Y, Greten FR, et al. NF-kappaB in cancer: From innocent bystander to major culprit. Nat Rev Cancer. 2002;2:301
  5. Abdel-Latif MM, O’Riordan J, Windle HJ, et al. NF-kappaB activation in esophageal adenocarcinoma: Relationship to Barrett’s metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg. 2004;239:491
  6. Chen X, Yang G, Ding WY, et al. An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. Carcinogenesis. 1999;20:1801
  7. Chen X, Li N, Wang S, et al. Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and alpha-difluoromethylornithine on tumorigenesis in a rat surgical model. Carcinogenesis. 2002;23:2095
  8. Buttar NS, Wang KK, Leontovich O, et al. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett’s esophagus. Gastroenterology. 2002;122:1101
  9. Couzin J. Drug safety (FDA panel urges caution on many anti-inflammatory drugs). Science. 2005;307:1183
  10. Wetscher GJ, Hinder PR, Bagchi D, et al. Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci. 1995;40:1292
  11. Oh TY, Lee JS, Ahn BO, et al. Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Gut. 2001;49:364
  12. Levrat M, Lambert R, Kirshbaum G. Esophagitis produced by reflux of duodenal contents in rats. Am J Dig Dis. 1962;7:564
  13. Oliveira CP, Kassab P, Lopasso FP, et al. Protective effect of ascorbic acid in experimental gastric cancer: Reduction of oxidative stress. World J Gastroenterol. 2003;9:446
  14. Screening Information Data Set (SIDS) on L-Ascorbic Acid (Vitamin C). Organisation for Economic Co-operation and Development, URL: http://wwwchemunepch/irptc/sids/OECDSIDS/50817htm Nov 1997, accessed April 20, 2005.
  15. Kubatka P, Ahlers I, Ahlersova E, et al. Chemoprevention of mammary carcinogenesis in female rats by rofecoxib. Cancer Lett. 2003;202:131
  16. Oshima M, Murai N, Kargman S, et al. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res. 2001;61:1733
  17. Rasband WS. ImageJ (Image analysis in Java). US National Institutes of Health, URL: http://rsbinfonihgov/ij/ 1997–2005, accessed November 6, 2005.
  18. Wei Y, Ota RB, Bowen HT, et al. Determination of human plasma and leukocyte ascorbic acid by microtiter plate assay. J Nutr Biochem. 1996;7:179
  19. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: The FRAP assay. Anal Biochem. 1996;239:70
  20. Miwa K, Sahara H, Segawa M, et al. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer. 1996;67:269
  21. Pera M, Trastek VF, Carpenter HA, et al. Influence of pancreatic and biliary reflux on the development of esophageal carcinoma. Ann Thorac Surg. 1993;55:1386;discussion 1392
  22. da Costa JM, Morales L, Garcia X, et al. [Reflux esophagitis in an experimental model. Are the systemic consequences attributable to the esophagitis?]. Cir Pediatr. 1993;6:196
  23. Kumagai H, Mukaisho K, Sugihara H, et al. Cell kinetic study on histogenesis of Barrett’s esophagus using rat reflux model. Scand J Gastroenterol. 2003;38:687
  24. Chen X, Mikhail SS, Ding YW, et al. Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats. Carcinogenesis. 2000;21:1531
  25. Van Den Boogert J, Van Hillegersberg R, De Bruin RW. Gastric perforation in WAG/Rij rats after esophagojejunostomy. Contemp Top Lab Anim Sci. 1999;38:50
  26. Mirvish SS. Studies on experimental animals involving surgical procedures and/or nitrosamine treatment related to the etiology of esophageal adenocarcinoma. Cancer Lett. 1997;117:161
  27. Goldstein NS, Yang GU, Curtis SK, et al. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis. 1997;18:2265
  28. Fein M, Peters JH, Chandrasoma P, et al. Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg. 1998;2:260
  29. Attwood SE, Smyrk TC, DeMeester TR, et al. Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery. 1992;111:503
  30. Oberg S, Lord RV, Peters JH, et al. Is adenocarcinoma following esophagoduodenostomy without carcinogen in the rat reflux-induced?. J Surg Res. 2000;91:111
  31. Ireland AP, Peters JH, Smyrk TC, et al. Gastric juice protects against the development of esophageal adenocarcinoma in the rat. Ann Surg. 1996;224:358;discussion 370
  32. Melo LL, Kruel CD, Kliemann LM, et al. Influence of surgically induced gastric and gastroduodenal content reflux on esophageal carcinogenesis—experimental model in Wistar female rats. Dis Esophagus. 1999;12:106
  33. Jang TJ, Min SK, Bae JD, et al. Expression of cyclooxygenase 2, microsomal prostaglandin E synthase 1, and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett’s metaplasia induced by duodenal contents reflux. Gut. 2004;53:27
  34. Pera M, Cardesa A, Bombi JA, et al. Influence of esophagojejunostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by subcutaneous injection of 2,6-dimethylnitrosomorpholine. Cancer Res. 1989;49:6803
  35. Sampliner RE. Effect of up to 3 years of high-dose lansoprazole on Barrett’s esophagus. Am J Gastroenterol. 1994;89:1844
  36. Lindblad M, Lagergren J, Garcia Rodriguez LA. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:444
  37. Bollschweiler E, Wolfgarten E, Nowroth T, et al. Vitamin intake and risk of subtypes of esophageal cancer in Germany. J Cancer Res Clin Oncol. 2002;128:575

PII: S0022-4804(07)00003-0

doi: 10.1016/j.jss.2007.01.002

Journal of Surgical Research
Volume 142, Issue 1 , Pages 20-27 , September 2007

Article Tools

* Image Usage & Resolution